Pure Global
NCT05649371

Multiphasic Prehab Allo-HSCT

A Multiphasic Prehabilitation Exercise Program For Allogeneic Hematopoietic Stem Cell Transplant Recipients
University of Calgary·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Leukemia
Drug/Device/Intervention
Prehabilitation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Calgary
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2023
End date
Dec 01, 2024
Enrollment
60 participants
Primary outcome

Feasibility of Implementing an Exercise Program for Patients Undergoing Allogeneic-HSCT, Measured by Participant Attendance

Summary

The purpose of this study is to implement a prehabilitation intervention to enhance recovery
 for people undergoing allogeneic stem cell transplant for hematologic malignancies. All
 participants in this study will receive a prehabilation intervention in addition to usual
 care (no change to their chemotherapy protocols or transplant) and several quality of life
 and fitness scores will be measured throughout the intervention.

ICD-10 classifications
Leukaemia, unspecifiedMyeloid leukaemiaMyeloid leukaemia, unspecifiedOther myeloid leukaemiaMonocytic leukaemia, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05649371
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05649371 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Calgary and is currently Not yet recruiting. The study focuses on Leukemia. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.